Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expert Opinion on Managing Adverse Reactions Associated With Acalabrutinib Therapy: A Delphi Consensus From France.
Ysebaert L, Ederhy S, Leblond V, Malartre S, Portalier A, Sibaud V, Tomowiak C, Zerbit J; Delphi Acalabrutinib Safety Study Group. Ysebaert L, et al. Among authors: zerbit j. Clin Lymphoma Myeloma Leuk. 2024 Oct 24:S2152-2650(24)02398-X. doi: 10.1016/j.clml.2024.10.013. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39547859 Review.
Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia.
Puisset F, Raffoux E, Ades L, Huynh T, Itzykson R, Bouscary D, Aguinana L, Rabian F, Sebert M, Vekhoff A, Brissot E, Mohty M, Bonnin A, Genthon A, Zerbit J, Willems L, Decrocq J, Contejean A, Lengline E, Mourah S, Goldwirt L. Puisset F, et al. Among authors: zerbit j. Haematologica. 2024 Oct 17. doi: 10.3324/haematol.2024.286062. Online ahead of print. Haematologica. 2024. PMID: 39415682 Free article.
Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.
Liévin R, Burroni B, Balducci E, Palmic P, Decroocq J, Deau-Fischer B, Franchi P, Vignon M, Zerbit J, Cottereau AS, Touzart A, Villarese P, Kaltenbach S, Lhermitte L, Asnafi V, Bouscary D, Willems L. Liévin R, et al. Among authors: zerbit j. Eur J Haematol. 2025 Jan;114(1):186-194. doi: 10.1111/ejh.14325. Epub 2024 Oct 12. Eur J Haematol. 2025. PMID: 39394958 Free PMC article.
Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study.
Pinson P, Boussaid I, Decroocq J, Chouchana L, Birsen G, Barrois M, Tsatsaris V, Godeberge C, Zerbit J, Burroni B, Pene F, Huynh L, Charlier C, Tamburini J, Beeker N, Collier M, Bouscary D, Treluyer JM, Birsen R. Pinson P, et al. Among authors: zerbit j. Lancet Haematol. 2024 Nov;11(11):e850-e861. doi: 10.1016/S2352-3026(24)00288-6. Epub 2024 Oct 7. Lancet Haematol. 2024. PMID: 39389070 Free article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
Detroit M, Collier M, Beeker N, Willems L, Decroocq J, Deau-Fischer B, Vignon M, Birsen R, Moufle F, Leclaire C, Balladur E, Deschamps P, Chauchet A, Batista R, Limat S, Treluyer JM, Ricard L, Stocker N, Hermine O, Choquet S, Morel V, Metz C, Bouscary D, Kroemer M, Zerbit J. Detroit M, et al. Among authors: zerbit j. Cancers (Basel). 2023 Aug 9;15(16):4028. doi: 10.3390/cancers15164028. Cancers (Basel). 2023. PMID: 37627056 Free PMC article.
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Zerbit J, Detroit M, Chevret S, Pene F, Luyt CE, Ghosn J, Eyvrard F, Martin-Blondel G, Sarton B, Clere-Jehl R, Moine P, Cransac A, Andreu P, Labruyère M, Albertini L, Huon JF, Roge P, Bernard L, Farines-Raffoul M, Villiet M, Venet A, Dumont LM, Kaiser JD, Chapuis C, Goehringer F, Barbier F, Desjardins S, Benzidi Y, Abbas N, Guerin C, Batista R, Llitjos JF, Kroemer M. Zerbit J, et al. J Clin Med. 2022 Nov 4;11(21):6545. doi: 10.3390/jcm11216545. J Clin Med. 2022. PMID: 36362773 Free PMC article.
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
Zerbit J, Kroemer M, Fuchs B, Detroit M, Decroocq J, Vignon M, Willems L, Deau-Fischer B, Franchi P, Deschamps P, Contejean A, Grignano E, Fouquet G, Birsen R, Mondesir J, Rocquet M, Huon JF, Batista R, Marty-Reboul J, Bouscary D. Zerbit J, et al. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13753. doi: 10.1111/ecc.13753. Epub 2022 Oct 23. Eur J Cancer Care (Engl). 2022. PMID: 36273820
22 results